Cannella, L.; Breccia, M.; Loglisci, G.; Federico, V.; Santopietro, M.; Alimena, G. Safety and Efficacy of Nilotinib in Chronic Phase Chronic Myeloid Leukemia in a Patient With Wolf-Parkinson-White Disease and Hematological Resistance After Suboptimal Response to Imatinib at Six Months. AO 2010, 49, 399-400.